Xenon Pharmaceuticals Inc Financial Flexibility Index
Xenon Pharmaceuticals Inc financial flexibility index. Xenon Pharmaceuticals Inc (XENE) has a Financial Flexibility Index of -0.20x as of December 2025. Free cash flow of $-81.16 Million (operating CF $-81.48 Million minus capex $318.00K) represents 0% of total liabilities ($399.91 Million). Explore capital reinvestment ratio of Xenon Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Xenon Pharmaceuticals Inc (2012–2025)
Financial flexibility index of Xenon Pharmaceuticals Inc from 2012 to 2025. Historical Financial Flexibility Index trend for Xenon Pharmaceuticals Inc across 14 annual periods. Check Xenon Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Xenon Pharmaceuticals Inc Financial Flexibility Index by Year (2012–2025)
Xenon Pharmaceuticals Inc financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Xenon Pharmaceuticals Inc. For the full cash flow conversion analysis, see XENE operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.70x | $-278.32 Million | $-279.12 Million | $399.91 Million | ▲ +83.1% |
| 2024 | -4.12x | $-178.31 Million | $-181.39 Million | $43.24 Million | ▼ -8.9% |
| 2023 | -3.79x | $-139.71 Million | $-145.33 Million | $36.88 Million | ▼ -29.5% |
| 2022 | -2.93x | $-95.54 Million | $-98.43 Million | $32.65 Million | ▲ +4.7% |
| 2021 | -3.07x | $-67.45 Million | $-69.50 Million | $21.97 Million | ▼ -20.3% |
| 2020 | -2.55x | $-45.49 Million | $-48.12 Million | $17.83 Million | ▼ -4090.5% |
| 2019 | -0.06x | $-3.39 Million | $-4.63 Million | $55.72 Million | ▲ +96.6% |
| 2018 | -1.79x | $-34.22 Million | $-34.72 Million | $19.13 Million | ▲ +35.9% |
| 2017 | -2.79x | $-28.41 Million | $-28.73 Million | $10.19 Million | ▲ +48.1% |
| 2016 | -5.38x | $-19.29 Million | $-19.57 Million | $3.59 Million | ▲ +10.7% |
| 2015 | -6.02x | $-17.55 Million | $-18.10 Million | $2.92 Million | ▼ -5010.6% |
| 2014 | 0.12x | $1.79 Million | $266.00K | $14.64 Million | ▲ +217.6% |
| 2013 | -0.10x | $-3.17 Million | $-3.32 Million | $30.37 Million | ▼ -111.5% |
| 2012 | 0.91x | $46.10 Million | $45.57 Million | $50.68 Million | — |